
|Articles|April 1, 2001
New drug for Alzheimer's
News brief.
Advertisement
Research Headlines
New drug for Alzheimer's
By Jeanne Sabatie, Production Editor
Reminyl has been approved by the FDA for the treatment of mild to moderate Alzheimer's disease. Clinical trials show that the drug, derived from the bulbs of daffodils, can improve patients' daily function and ability to think. The Rx drug is scheduled to be available in May.
Jeanne Sabatie. New drug for Alzheimer's.
Business and Health
2001;4:10.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
What IRA drug prices will mean for PBMs, health plans and patients
2
Looking ahead: What the MHE 2025 State of the Industry survey tells us about 2026
3
Biosimilar competition could surpass IRA-negotiated savings by year three
4
Midlife influenza vaccine not associated with increased risk of Parkinson’s disease, study shows
5





















































